The Role of Pharmacists’ Interventions in Increasing Medication Adherence of Patients With Epilepsy: A Scoping Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Epilepsy is a chronic disease that requires long-term treatment and intervention from health workers. Medication adherence is a factor that influences the success of therapy for patients with epilepsy. Therefore, this study aimed to analyze the role of pharmacists in improving the clinical outcomes of epilepsy patients, focusing on medication adherence.Methods: A scoping literature search was conducted through the ScienceDirect, PubMed, and Google Scholar databases. The literature search included all original articles published in English until August 2023 for which the full text was available. This scoping review was carried out by a team consisting of pharmacists and neurologists following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews and the Joanna Briggs Institute guidelines, including 5 steps: identifying research questions, finding relevant articles, selecting articles, presenting data, and compiling the results.Results: The literature search yielded 10 studies that discussed pharmacist interventions for patients with epilepsy. Five articles described educational interventions involving drug-related counseling with pharmacists. Two articles focused on similar pharmacist interventions through patient education, both verbal and written. Three articles discussed an epilepsy review service, a multidisciplinary intervention program involving pharmacists and other health workers, and a mixed intervention combining education and training with therapy-based behavioral interventions.Conclusions: Pharmacist interventions have been shown to be effective in improving medication adherence in patients with epilepsy. Furthermore, these interventions play a crucial role in improving other therapeutic outcomes, including patients’ knowledge of self-management, perceptions of illness, the efficacy of antiepileptic drugs in controlling seizures, and overall quality of life.
Abstract
Objectives: Epilepsy is a chronic disease that requires long-term treatment and intervention from health workers. Medication adherence is a factor that influences the success of therapy for patients with epilepsy. Therefore, this study aimed to analyze the role of pharmacists in improving the clinical outcomes of epilepsy patients, focusing on medication adherence.Methods: A scoping literature search was conducted through the ScienceDirect, PubMed, and Google Scholar databases. The literature search included all original articles published in English until August 2023 for which the full text was available. This scoping review was carried out by a team consisting of pharmacists and neurologists following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews and the Joanna Briggs Institute guidelines, including 5 steps: identifying research questions, finding relevant articles, selecting articles, presenting data, and compiling the results.Results: The literature search yielded 10 studies that discussed pharmacist interventions for patients with epilepsy. Five articles described educational interventions involving drug-related counseling with pharmacists. Two articles focused on similar pharmacist interventions through patient education, both verbal and written. Three articles discussed an epilepsy review service, a multidisciplinary intervention program involving pharmacists and other health workers, and a mixed intervention combining education and training with therapy-based behavioral interventions.Conclusions: Pharmacist interventions have been shown to be effective in improving medication adherence in patients with epilepsy. Furthermore, these interventions play a crucial role in improving other therapeutic outcomes, including patients’ knowledge of self-management, perceptions of illness, the efficacy of antiepileptic drugs in controlling seizures, and overall quality of life.
참고문헌 (41)
- Wirrell EC, "Epilepsy", pp.11~22 (2021), John Wiley & Sons
- Aminoff M, "Current medical diagnosis & treatment", pp.987~991 (2022), McGraw Hill Education
- "Epilepsy" (2023)[URL]
- Bonnett LJ, "Time to 12-month remission and treatment failure for generalised and unclassified epilepsy", J Neurol Neurosurg Psychiatry, 85(6), pp.603~610 (2014)[DOI]
- French JA, "Clinical practice. Initial management of epilepsy", N Engl J Med, 359(2), pp.166~176 (2008)[DOI]
- "Adherence to long-term therapies: evidence for action" (2003)[URL]
- AlAjmi R, "The impact of a pharmacist-led educational interview on medication adherence of Saudi patients with epilepsy", Patient Prefer Adherence, 11, pp.959~964 (2017)[DOI]
- Faught RE, "Impact of nonadherence to antiepileptic drugs on health care utilization and costs : findings from the RANSOM study", Epilepsia, 50(3), pp.501~509 (2009)[DOI]
- Lie IA, "Treatment non-adherence as a trigger for status epilepticus : an observational, retrospective study based on therapeutic drug monitoring", Epilepsy Res, 113, pp.28~33 (2015)[DOI]
- Chen Z, "Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs : a 30-year longitudinal cohort study", JAMA Neurol, 75(3), pp.279~286 (2018)[DOI]
- Rohde NN, "Antiepileptic drug prescribing patterns in Iraq and Afghanistan war veterans with epilepsy", Epilepsy Behav, 46, pp.133~139 (2015)[DOI]
- Moseley BD, "A review of the drug-drug interactions of the antiepileptic drug brivaracetam", Epilepsy Res, 163, pp.106327~ (2020)[DOI]
- Mutanana N, "General side effects and challenges associated with anti-epilepsy medication : a review of related literature", Afr J Prim Health Care Fam Med, 12(1), pp.e1~e5 (2020)[DOI]
- Bacci JL, "Community pharmacists’ role in caring for people living with epilepsy : a scoping review", Epilepsy Behav, 117, pp.107850~ (2021)[DOI]
- Ratanajamit C, "Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs", J Med Assoc Thai, 92(11), pp.1500~1507 (2009)
- Ernawati I, "How to improve clinical outcome of epileptic seizure control based on medication adherence? A literature review", Open Access Maced J Med Sci, 6(6), pp.1174~1179 (2018)[DOI]
- Reis TM, "Contributions of pharmacists in the treatment of epilepsy : a systematic review", Am J Pharm Benefits, 8(3), pp.e55~e60 (2016)
- Taube M, "Impact of clinical pharmacists on access to care in an epilepsy clinic", Fed Pract, 39(Suppl 1), pp.S5~S9 (2022)[DOI]
- Peters MD, "Guidance for conducting systematic scoping reviews", Int J Evid Based Healthc, 13(3), pp.141~146 (2015)[DOI]
- Tricco AC, "PRISMA extension for scoping reviews(PRISMA-ScR) : checklist and explanation", Ann Intern Med, 169(7), pp.467~473 (2018)[DOI]
- Fogg A, "An exploratory study of primary care pharmacist-led epilepsy consultations", Int J Pharm Pract, 20(5), pp.294~302 (2012)[DOI]
- Tang F, "The effects of medication education and behavioral intervention on Chinese patients with epilepsy", Epilepsy Behav, 37, pp.157~164 (2014)[DOI]
- Li WS, "The impact of epilepsy review service on seizure control in primary care", Pharm Res Rep, 1, pp.32~41 (2018)
- Jinil AL, "Impact of counseling on patient caretaker’s knowledge and medication adherence to paediatric antiepileptic drug therapy", Int J Sci Healthc Res, 3(4), pp.158~165 (2018)
- Ma M, "Pharmacist impact on adherence of valproic acid therapy in pediatric patients with epilepsy using active education techniques", Epilepsy Behav, 98(Pt A), pp.14~18 (2019)[DOI]
- Zheng Y, "Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China : a prospective study", Epilepsy Behav, 100(Pt A), pp.106400~ (2019)[DOI]
- Chandrasekhar D, "Impact of clinical pharmacist managed patient counselling on the knowledge and adherence to antiepileptic drug therapy", Clin Epidemiol Glob Health, 8(4), pp.1242~1247 (2020)[DOI]
- Jarad S, "The role of clinical pharmacist in pediatrics’ adherence to antiepileptic drugs", J Pharm Technol, 38(5), pp.272~282 (2022)[DOI]
- Tamilselvan T, "Impact of pharmacist assisted patient counselling in improving medication adherence and quality of life in epileptic patients", Sch J App Med Sci, 10(6), pp.1012~1015 (2022)[DOI]
- Özdağ E, "Pharmacist’s impact on medication adherence and drug-related problems in patients with epilepsy", Turk J Pharm Sci, 20(6), pp.361~367 (2024)[DOI]
- Haut SR, "Behavioral interventions in epilepsy", Curr Opin Neurol, 32(2), pp.227~236 (2019)[DOI]
- Al-Aqeel S, "Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy", Cochrane Database Syst Rev, 10(10), pp.CD008312~ (2020)[DOI]
- Yilmazel G, "Teachers’ negative attitudes and limited health literacy levels as risks for low awareness of epilepsy in Turkey", J Prev Med Public Health, 56(6), pp.573~582 (2023)[DOI]
- Boon P, "Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium : 2020 update", Acta Neurol Belg, 121(1), pp.241~257 (2021)[DOI]
- Marawar R, "Implementation of an older adult epilepsy clinic utilizing pharmacist services", J Am Pharm Assoc(2003), 61(6), pp.e93~e98 (2021)[DOI]
- Eshiet UI, "Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy : a randomized controlled trial", Epilepsy Res, 174, pp.106648~ (2021)[DOI]
- Michaelis R, "Psychological treatments for people with epilepsy", Cochrane Database Syst Rev, 10(10), pp.CD012081~ (2017)[DOI]
- Pandey DK, "Self-management skills and behaviors, self-efficacy, and quality of life in people with epilepsy from underserved populations", Epilepsy Behav, 98(Pt A), pp.258~265 (2019)[DOI]
- Belayneh Z, "A systematic review and meta-analysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia", Arch Public Health, 78, pp.23~ (2020)[DOI]
- Niriayo YL, "Treatment outcome and associated factors among patients with epilepsy", Sci Rep, 8(1), pp.17354~ (2018)[DOI]
- Paschal AM, "Measures of adherence to epilepsy treatment : review of present practices and recommendations for future directions", Epilepsia, 49(7), pp.1115~1122 (2008)[DOI]
